HUM vs INVA · P/E 39, rev $117.76B vs P/E 3.6, rev $358.7M
Humana Inc (HUM) versus Innoviva Inc (INVA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Innoviva Inc (INVA) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported INVA revenue for 2024-12-31 was $358.7M. Net income was $23.4M. Revenue was up 15.5% from 2023-12-31 to 2024-12-31. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
Not investment advice. Open the HUM and INVA stock pages for the full models.
Not investment advice.